Krystal Biotech

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KRYS and other ETFs, options, and stocks.

About KRYS

Krystal Biotech, Inc. operates as a biotechnology company, which engages in discovery, development, manufacturing, and commercialization of pharmaceutical products. It offers the product, VYJUVEK. 

CEO
Krish S. Krishnan
CEOKrish S. Krishnan
Employees
295
Employees295
Headquarters
Pittsburgh, Pennsylvania
HeadquartersPittsburgh, Pennsylvania
Founded
2016
Founded2016
Employees
295
Employees295

KRYS Key Statistics

Market cap
10.03B
Market cap10.03B
Price-Earnings ratio
45.90
Price-Earnings ratio45.90
Dividend yield
Dividend yield
Average volume
392.92K
Average volume392.92K
High today
High today
Low today
Low today
Open price
$337.60
Open price$337.60
Volume
0.00
Volume0.00
52 Week high
$356.50
52 Week high$356.50
52 Week low
$130.50
52 Week low$130.50

Stock Snapshot

As of today, Krystal Biotech(KRYS) shares are valued at $340.21. The company's market cap stands at 10.03B, with a P/E ratio of 45.90.

During the trading day, Krystal Biotech(KRYS) stock saw an opening price of $337.60, a peak of —, and a bottom of —.

Trading activity shows a volume of 0, compared to an average daily volume of 392.92K.

The stock's 52-week range extends from a low of $130.50 to a high of $356.50.

The stock's 52-week range extends from a low of $130.50 to a high of $356.50.

KRYS News

Simply Wall St 2d
Krystal Biotech Is Up 7.2% After Institutional Ownership Surges To Sector-Leading Levels - simplywall.st

...

Krystal Biotech Is Up 7.2% After Institutional Ownership Surges To Sector-Leading Levels - simplywall.st
Nasdaq 6d
These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead

Key Points Moderna is racing towards important clinical and regulatory catalysts. Krystal Biotech still has a large market to address in its core area. AMD i...

These 3 Stocks Have Crushed the Market This Year. Here's Why There Is More Upside Ahead

Analyst ratings

92%

of 12 ratings
Buy
91.7%
Hold
8.3%
Sell
0%

People also own

Based on the portfolios of people who own KRYS. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.